<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

Neuro Therapies

Challenges and Opportunities in the Endovascular Treatment of Cerebral Venous Disorders

Ferdinand Hui, MD, discusses the endovascular treatment of cerebral venous disorders, a potentially vast...

Neuro Therapies

Neurovascular Intervention: Trends to Watch in 2026

SmartTRAK highlights three neurointerventional trends to watch in 2026. SmartTRAK highlights recent news...

Neuro Therapies

NANS 2026: Abbott's Vision for Neuromodulation

Abbott‘s VP of Neuromodulation Ryan Lakin discusses his vision for neuromodulation and trends in the mar...

Neuro Therapies

Super-Bore Catheters 2025: An Interview with Raul Nogueira, MD

Raul Nogueira, MD, discusses the latest research and innovation in super-bore catheters for the treatmen...

Neuro Therapies

SNIS 2025: Spotlight on Q'Apel Medical

Stewart Strong, Q’Apel Medical’s recently appointed CEO, discusses the company, his priorities and plans...

Neuro Therapies

SmartTRAK at SNIS 2025

SmartTRAK is excited to attend the Society of Neurointerventional Surgery’s (SNIS) 22nd Annual Meeting &...

Neuro Therapies

Scientia Vascular: Innovating to Disrupt Stroke Care

Scientia Vascular CEO Rick Randall discusses the company, its novel technology and plans for growth in a...

Neuro Therapies

Perfuze: Building, Innovating and Simplifying Stroke Care

Perfuze CEO Wayne Allen discusses the company, its novel technology and how the company plans to capture...

Neuro Therapies

NANS 2025: Charting New Territory With Ultra-Low Frequency Spinal Cord Stimulation

Dr. Marc Russo discusses his research on ultra-low frequency SCS and its potential to treat nociceptive ...

Neuro Therapies

Terumo Neuro: Aiming for #1 in Neurovascular

Carsten Schroeder, president and CEO of Terumo Neuro, discusses the company’s plans to capture share and...

1 2 3 4 5
...
12